《公司業績》維他奶(00345.HK)全年虧轉盈賺4,572.1萬元 末期息1.4仙
維他奶國際(00345.HK)公布截至今年3月底止全年業績,期內扭虧為盈賺4,572.1萬元,上年同期蝕1.59億元;每股盈利4.3仙。派末期息1.4仙,上年同期不派息。連同中期股息1.3仙,全年度將派發股息共2.7仙。
年內收入達約63.41億元,按年跌2.5%,集團解釋是人民幣及澳元貶值的影響,若撇除匯率影響全年收入增長2%。維他奶表示,撇除匯率影響後已恢復盈利能力及收入增長,未來將繼續提升銷售執行及擴大產品銷售渠道,目標於截至明年3月底止年度保持盈利增長。
按地區劃分,中國內地業務以當地貨幣計算的收入按年減少2%,香港特區業務收入及經營溢利較去年達雙位數增長。公司於今年2月完成收購 Vitasoy Australia Products Pty. Ltd.餘下 49%股權,年內澳洲及新西蘭市場以當地貨幣計算收入按年升3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.